Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akari Therapeutics ADR (NQ: AKTX )

3.660 -0.020 (-0.54%)
Streaming Delayed Price Updated: 3:55 PM EDT, Sep 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Akari Therapeutics ADR

< Previous 1 2 Next >
Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session
Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. 
Via Benzinga
Dow Jumps 250 Points; Crude Oil Rises Over 1%
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Monday. 
Via Benzinga
Why Akari Therapeutics Shares Are Getting Obliterated
Akari Therapeutics PLC (NASDAQ: AKTX) shares are trading lower by 26.92% to $0.76 Monday morning after the company announced a $12.75 million registered direct offering. What Else? 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million. 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Dare Bioscience (NASDAQ:DARE) shares increased by 51.97% to $2.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers BioLine Rx (NASDAQ:BLRX) shares moved upwards by 65.2% to $5.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $226.7... 
Via Benzinga
Akari Therapeutics' Nomacopan Secures Expediated Review Tag For Blistering Skin Disorder
The FDA has granted Fast Track designation to Akari Therapeutics Plc's (NASDAQ: AKTX) nomacopan to treat patients with moderate and severe Bullous... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Akari Therapeutics (NASDAQ:AKTX) stock moved upwards by 14.1% to $2.67 during Wednesday's pre-market session. The company's market cap stands at $102.7... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Obalon Therapeutics (NASDAQ:OBLN) shares moved upwards by 6.04% to $2.63 during Monday's after-market session. At the close, Obalon Therapeutics's trading volume... 
Via Benzinga
25 Stocks Moving in Tuesday's Pre-Market Session
Gainers Dragon Victory International Limited (NASDAQ: LYL) rose 52.1% to $2.16 in pre-market trading after dropping around 8% on Monday. Mackinac Financial Corporation (NASDAQ:... 
Via Benzinga
Akari Therapeutics' To Go With Pivotal Bullous Pemphigoid Study With Nomacopan
The FDA has opened the investigational new drug application for Phase 3 trial for Akari Therapeutics Plc's (NASDAQ: AKTX) lead drug candidate,... 
Via Benzinga
Exposures Product Safety
42 Stocks Moving In Monday's Mid-Day Session
Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 44.8% to $8.05 after the company's 13D filing showed that Modell's Sporting Goods had reported a stake... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.